Effect of PDE4 inhibitors on zymosan-induced IL-8 release from human neutrophils: synergism with prostanoids and salbutamol-Reference-Cited by-同舟云学术

Effect of PDE4 inhibitors on zymosan-induced IL-8 release from human neutrophils: synergism with prostanoids and salbutamol

Published:1998-03 Issue:6 Volume:123 Page:1260-1266
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:

Author:

Au B- T.,Teixeira M M.,Collins P D.,Williams T J.

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1038/sj.bjp.0701723/fullpdf

Reference41 articles.

1. Zymosan-induced interleukin-8 release from human neutrophils involves activation via the Cd11b/CD18 receptor and endogenous platelet activating factor as an autocrine modulator;Au;J. Immunol.,1994

2. Interleukin-8, a chemotactic and inflammatory cytokine;Baggiolini;FEES Letts,1992

3. Sb 207499, a potent and selective phosphodiesterase (PDE) Iv inhibitor, suppresses activates of several immune and inflammatory cells;Barnette;Am. J. Resp. Crit. Care. Med.,1994

4. Phagocytosing neutrophils produce and release high amounts of the neutrophil-activating peptide 1/interleukin 8;Bazzoni;J. Exp. Med.,1991

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Scope of adjuvant therapy using roflumilast, a PDE-4 inhibitor against COVID-19;Pulmonary Pharmacology & Therapeutics;2021-02

2. Blame the signaling: Role of cAMP for the resolution of inflammation;Pharmacological Research;2020-09

3. Roflumilast Inhibits Lipopolysaccharide-Induced Tumor Necrosis Factor-α and Chemokine Production by Human Lung Parenchyma;PLoS ONE;2013-09-16

4. Inhibition of phosphodiesterase 4 modulates cytokine induction from toll like receptor activated, but not rhinovirus infected, primary human airway smooth muscle;Respiratory Research;2013

5. Apremilast mechanism of action and application to psoriasis and psoriatic arthritis;Biochemical Pharmacology;2012-06